Fresenius Medical Care AG & Co. KGaA (ETR:FME) has been given a €92.10 ($108.35) target price by stock analysts at Berenberg Bank in a research report issued on Monday. The brokerage presently has a “buy” rating on the stock.

A number of other brokerages also recently weighed in on FME. Morgan Stanley set a €90.00 ($105.88) price objective on shares of Fresenius Medical Care AG & Co. KGaA and gave the company a “buy” rating in a research report on Friday, May 5th. Nord/LB set a €93.00 ($109.41) target price on shares of Fresenius Medical Care AG & Co. KGaA and gave the company a “buy” rating in a research note on Thursday, May 4th. J P Morgan Chase & Co set a €104.50 ($122.94) target price on shares of Fresenius Medical Care AG & Co. KGaA and gave the company a “buy” rating in a research note on Thursday, May 4th. S&P Global set a €88.00 ($103.53) target price on shares of Fresenius Medical Care AG & Co. KGaA and gave the company a “neutral” rating in a research note on Wednesday, May 3rd. Finally, Kepler Capital Markets set a €95.00 ($111.76) target price on shares of Fresenius Medical Care AG & Co. KGaA and gave the company a “buy” rating in a research note on Wednesday, May 3rd. Two investment analysts have rated the stock with a sell rating, nine have assigned a hold rating and ten have assigned a buy rating to the company’s stock. The stock currently has an average rating of “Hold” and a consensus target price of €88.07 ($103.61).

Shares of Fresenius Medical Care AG & Co. KGaA (FME) opened at 77.40 on Monday. The firm has a market cap of €23.75 billion and a P/E ratio of 19.96. The stock’s 50 day moving average is €84.82 and its 200 day moving average is €81.05. Fresenius Medical Care AG & Co. KGaA has a 52 week low of €70.82 and a 52 week high of €89.07.

ILLEGAL ACTIVITY WARNING: This article was first reported by Daily Political and is owned by of Daily Political. If you are accessing this article on another publication, it was illegally copied and republished in violation of international copyright and trademark law. The original version of this article can be accessed at https://www.dailypolitical.com/2017/08/07/fresenius-medical-care-ag-92-10-price-target-at-berenberg-bank.html.

Fresenius Medical Care AG & Co. KGaA Company Profile

Fresenius Medical Care AG & Co KGaA, a kidney dialysis company, provides dialysis care and related services, and other health care services. It offers dialysis treatment, and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized ESRD patients and for patients suffering from acute kidney failure.

Analyst Recommendations for Fresenius Medical Care AG & Co. KGaA (ETR:FME)

Receive News & Ratings for Fresenius Medical Care AG & Co. KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fresenius Medical Care AG & Co. KGaA and related companies with MarketBeat.com's FREE daily email newsletter.